003090.KS
Daewoong Co., Ltd.
KSC · Healthcare · Drug Manufacturers - General · KR
KRW 17,200.00
−1.43%Margins
Gross margin
52.3%
EBITDA margin
15.7%
EBIT margin
11.3%
Net margin
8.5%
FCF margin
-3.7%
14.3%
Return on equity
5.2%
Return on assets
10.8%
Return on invested capital
0.62x
Asset turnover
KRW 256.8B
Cash from operations
KRW 5.1K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026